Prognostic impact of CD133 expression in Endometrial Cancer Patients

To assess the impact of CD133 expression on the prognosis of endometrioid endometrial carcinoma (EEC). We retrospectively assessed CD133 expression in tissue microarray of 116 surgically treated FIGO I-III EEC. Tumors with ≥10% of CD133-expressing cells were considered CD133-positive (CD133+). On th...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Sci Rep
Main Authors: Mancebo, G., Sole-Sedeno, J. M., Pino, O., Miralpeix, E., Mojal, S., Garrigos, L., Lloveras, B., Navarro, P., Gibert, J., Lorenzo, M., Aran, I., Carreras, R., Alameda, F.
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group UK 2017
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5550511/
https://ncbi.nlm.nih.gov/pubmed/28794448
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-017-08048-0
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki